The World Health Organization authorizes a second vaccine against dengue

The World Health Organization authorizes a second vaccine against dengue

Geneva – The World Health Organization (WHO) authorized on Wednesday a second vaccine against denguewith the idea of ​​providing protection to millions of people around the world against the mosquito-borne disease that has already caused numerous outbreaks in the American continent this year.

In a statement on Wednesday, the health agency UN said it approved the dengue vaccine manufactured by Japanese pharmaceutical company Takeda, recommending its use in children between 6 and 16 years old who live in regions with high rates of dengue. The two-dose vaccine protects against all four types of dengue.

Takeda’s vaccine, known as Qdenga, was approved by the European Medicines Agency in 2022.

The WHO approval now means donors and other UN agencies can buy the vaccine for poorer countries.

Studies have shown that Takeda’s vaccine is 84% ​​effective in preventing people from being hospitalized for dengue and 61% effective in stopping symptoms.

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!

LEAVE A REPLY

Please enter your comment!
Please enter your name here